

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.44897064 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.44897064 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.16823853 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.16823853 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.56358691 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95221779 |
| 7 | urea cycle (GO:0000050) | 5.80272304 |
| 8 | urea metabolic process (GO:0019627) | 5.80272304 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.76013030 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.76013030 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.76013030 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.59021070 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.53030034 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.52070890 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.39943898 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.38290018 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.36575029 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 5.34356578 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.33704634 |
| 20 | regulation of protein activation cascade (GO:2000257) | 5.32112298 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.23161149 |
| 22 | protein carboxylation (GO:0018214) | 5.23161149 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.20993047 |
| 24 | cysteine metabolic process (GO:0006534) | 5.15398037 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.10556378 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.10135520 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 5.00242431 |
| 28 | regulation of complement activation (GO:0030449) | 4.99719325 |
| 29 | regulation of plasminogen activation (GO:0010755) | 4.97894522 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.97075289 |
| 31 | collagen fibril organization (GO:0030199) | 4.90631065 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 4.90019691 |
| 33 | tyrosine metabolic process (GO:0006570) | 4.85386257 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.74753601 |
| 35 | bile acid metabolic process (GO:0008206) | 4.72075255 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65582724 |
| 37 | acylglycerol homeostasis (GO:0055090) | 4.59223902 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.59223902 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.51328752 |
| 40 | lysine catabolic process (GO:0006554) | 4.50173591 |
| 41 | lysine metabolic process (GO:0006553) | 4.50173591 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.49576127 |
| 43 | plasma lipoprotein particle clearance (GO:0034381) | 4.48454582 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.45854177 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.43873660 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.43873660 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43873660 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.39474183 |
| 49 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.30871892 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.30364403 |
| 51 | phospholipid efflux (GO:0033700) | 4.18198172 |
| 52 | cellular amino acid catabolic process (GO:0009063) | 4.16711402 |
| 53 | negative regulation of protein activation cascade (GO:2000258) | 4.16149805 |
| 54 | cell migration involved in heart development (GO:0060973) | 4.15937213 |
| 55 | arginine metabolic process (GO:0006525) | 4.13856072 |
| 56 | protein heterotrimerization (GO:0070208) | 4.13197788 |
| 57 | epoxygenase P450 pathway (GO:0019373) | 4.10929570 |
| 58 | negative regulation of cholesterol transport (GO:0032375) | 4.03626939 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.03626939 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.01883415 |
| 61 | glycine metabolic process (GO:0006544) | 3.96794447 |
| 62 | amine catabolic process (GO:0009310) | 3.95273675 |
| 63 | cellular biogenic amine catabolic process (GO:0042402) | 3.95273675 |
| 64 | fibrinolysis (GO:0042730) | 3.94209724 |
| 65 | extracellular fibril organization (GO:0043206) | 3.94201871 |
| 66 | endodermal cell differentiation (GO:0035987) | 3.93710846 |
| 67 | negative regulation of complement activation (GO:0045916) | 3.91941205 |
| 68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.91846583 |
| 69 | cellular glucuronidation (GO:0052695) | 3.90452143 |
| 70 | glutamate metabolic process (GO:0006536) | 3.90021724 |
| 71 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.89786439 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 3.89736958 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.88571805 |
| 74 | negative regulation of lipase activity (GO:0060192) | 3.88359003 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 3.86115567 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.85795346 |
| 77 | peptidyl-proline hydroxylation (GO:0019511) | 3.85226996 |
| 78 | acetyl-CoA metabolic process (GO:0006084) | 3.84771458 |
| 79 | bile acid and bile salt transport (GO:0015721) | 3.84444128 |
| 80 | imidazole-containing compound metabolic process (GO:0052803) | 3.83686943 |
| 81 | aldehyde catabolic process (GO:0046185) | 3.83539126 |
| 82 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.82487989 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 3.82125859 |
| 84 | acute-phase response (GO:0006953) | 3.80506361 |
| 85 | cholesterol efflux (GO:0033344) | 3.79452658 |
| 86 | skin morphogenesis (GO:0043589) | 3.79098425 |
| 87 | complement activation (GO:0006956) | 3.73800592 |
| 88 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.72192381 |
| 89 | cytolysis (GO:0019835) | 3.71689970 |
| 90 | ethanol oxidation (GO:0006069) | 3.71419079 |
| 91 | cofactor catabolic process (GO:0051187) | 3.70582106 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.69330092 |
| 93 | organic acid catabolic process (GO:0016054) | 3.69330092 |
| 94 | complement activation, classical pathway (GO:0006958) | 3.69007375 |
| 95 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68811181 |
| 96 | cell adhesion mediated by integrin (GO:0033627) | 3.67993350 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 3.66349149 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65015844 |
| 99 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65015844 |
| 100 | opsonization (GO:0008228) | 3.64686716 |
| 101 | plasma lipoprotein particle assembly (GO:0034377) | 3.64440004 |
| 102 | drug catabolic process (GO:0042737) | 3.64406900 |
| 103 | protein activation cascade (GO:0072376) | 3.62873168 |
| 104 | type B pancreatic cell proliferation (GO:0044342) | 3.59860644 |
| 105 | 2-oxoglutarate metabolic process (GO:0006103) | 3.58077229 |
| 106 | keratan sulfate catabolic process (GO:0042340) | 3.57202287 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.56197891 |
| 108 | sterol homeostasis (GO:0055092) | 3.50525333 |
| 109 | fatty acid beta-oxidation (GO:0006635) | 3.50195698 |
| 110 | blood coagulation, intrinsic pathway (GO:0007597) | 3.49820958 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.49510340 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.49508248 |
| 113 | fatty acid oxidation (GO:0019395) | 3.48857050 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.47880091 |
| 115 | glucuronate metabolic process (GO:0019585) | 3.47880091 |
| 116 | short-chain fatty acid metabolic process (GO:0046459) | 3.46874579 |
| 117 | cellular response to zinc ion (GO:0071294) | 3.45954717 |
| 118 | heme transport (GO:0015886) | 3.44694365 |
| 119 | omega-hydroxylase P450 pathway (GO:0097267) | 3.44651935 |
| 120 | membrane raft organization (GO:0031579) | 3.39684446 |
| 121 | positive regulation of extracellular matrix organization (GO:1903055) | 3.39230468 |
| 122 | fibril organization (GO:0097435) | 3.38877438 |
| 123 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.35935099 |
| 124 | protein hydroxylation (GO:0018126) | 3.34315039 |
| 125 | kidney mesenchyme development (GO:0072074) | 3.33849124 |
| 126 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.27193574 |
| 127 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.26910555 |
| 128 | metanephric mesenchyme development (GO:0072075) | 3.18161470 |
| 129 | protein retention in ER lumen (GO:0006621) | 3.16602347 |
| 130 | extracellular matrix assembly (GO:0085029) | 3.16318693 |
| 131 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.16265000 |
| 132 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.13856274 |
| 133 | regulation of metalloenzyme activity (GO:0048552) | 3.13711006 |
| 134 | venous blood vessel morphogenesis (GO:0048845) | 3.11655362 |
| 135 | endocrine hormone secretion (GO:0060986) | 3.08766399 |
| 136 | lymphangiogenesis (GO:0001946) | 3.07878876 |
| 137 | tooth mineralization (GO:0034505) | 3.05192913 |
| 138 | regulation of extracellular matrix disassembly (GO:0010715) | 3.04518574 |
| 139 | negative regulation of coagulation (GO:0050819) | 3.03746096 |
| 140 | endothelial cell morphogenesis (GO:0001886) | 3.02078601 |
| 141 | basement membrane organization (GO:0071711) | 3.01185547 |
| 142 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.00414201 |
| 143 | glomerular basement membrane development (GO:0032836) | 3.00355078 |
| 144 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92544238 |
| 145 | negative regulation of wound healing (GO:0061045) | 2.91680169 |
| 146 | 4-hydroxyproline metabolic process (GO:0019471) | 2.90593905 |
| 147 | collagen metabolic process (GO:0032963) | 2.90508719 |
| 148 | adhesion of symbiont to host cell (GO:0044650) | 2.89875635 |
| 149 | virion attachment to host cell (GO:0019062) | 2.89875635 |
| 150 | negative regulation of blood coagulation (GO:0030195) | 2.89470438 |
| 151 | negative regulation of hemostasis (GO:1900047) | 2.89470438 |
| 152 | negative regulation of fatty acid transport (GO:2000192) | 2.88267887 |
| 153 | extracellular matrix disassembly (GO:0022617) | 2.86644108 |
| 154 | extracellular matrix organization (GO:0030198) | 2.84750211 |
| 155 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.84133371 |
| 156 | extracellular structure organization (GO:0043062) | 2.83703462 |
| 157 | barbed-end actin filament capping (GO:0051016) | 2.81974412 |
| 158 | blood vessel maturation (GO:0001955) | 2.79417261 |
| 159 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.78429817 |
| 160 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.77096636 |
| 161 | hyaluronan catabolic process (GO:0030214) | 2.76465679 |
| 162 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.74163537 |
| 163 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.72372155 |
| 164 | negative regulation of humoral immune response (GO:0002921) | 2.70972674 |
| 165 | positive regulation of osteoblast proliferation (GO:0033690) | 2.70154578 |
| 166 | collagen catabolic process (GO:0030574) | 2.67030010 |
| 167 | acute inflammatory response (GO:0002526) | 2.65681736 |
| 168 | regulation of apoptotic cell clearance (GO:2000425) | 2.65244044 |
| 169 | multicellular organismal metabolic process (GO:0044236) | 2.63445842 |
| 170 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.61937589 |
| 171 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.60238052 |
| 172 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.60029545 |
| 173 | cellular response to cadmium ion (GO:0071276) | 2.59532555 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.59444256 |
| 175 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.59012254 |
| 176 | apoptotic cell clearance (GO:0043277) | 2.58464056 |
| 177 | COPI coating of Golgi vesicle (GO:0048205) | 2.58174145 |
| 178 | Golgi transport vesicle coating (GO:0048200) | 2.58174145 |
| 179 | COPII vesicle coating (GO:0048208) | 2.57224224 |
| 180 | exogenous drug catabolic process (GO:0042738) | 2.57095486 |
| 181 | adhesion of symbiont to host (GO:0044406) | 2.55334578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.96876714 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.74293287 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.52611937 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.40349069 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.14685410 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.13189608 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.90683283 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.92457198 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.79280979 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.61938349 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.90395522 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.84442074 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.80505744 |
| 14 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.52565933 |
| 15 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.52051662 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.49481261 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.31265460 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04610918 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.01917515 |
| 20 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4040915 |
| 21 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98814226 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.95327548 |
| 23 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.95327548 |
| 24 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.91131987 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.87007825 |
| 26 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.86046151 |
| 27 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.85151316 |
| 28 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77362041 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56207571 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56122682 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.49931780 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.49296475 |
| 33 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.47454665 |
| 34 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44706703 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42728558 |
| 36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.41373247 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40776968 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39980201 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38730683 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33597975 |
| 41 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.33306200 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31084853 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.29169133 |
| 44 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.28931831 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25781274 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24569154 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23450564 |
| 48 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22683258 |
| 49 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.22349041 |
| 50 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.19780998 |
| 51 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.18954024 |
| 52 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16908216 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.16795269 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15794036 |
| 55 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15599406 |
| 56 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.14412372 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12909791 |
| 58 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11051687 |
| 59 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10854296 |
| 60 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.10423256 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09671183 |
| 62 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.09352655 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03999080 |
| 64 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01746962 |
| 65 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98769023 |
| 66 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97799166 |
| 67 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.96873106 |
| 68 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.94886437 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91834624 |
| 70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91124256 |
| 71 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.90959251 |
| 72 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90572662 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89675309 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88549924 |
| 75 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88290286 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88202283 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88202283 |
| 78 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86866665 |
| 79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86767535 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85406397 |
| 81 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85370606 |
| 82 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84848014 |
| 83 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84112210 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83991011 |
| 85 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.83041554 |
| 86 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82808429 |
| 87 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82205532 |
| 88 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81171852 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80975863 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80356109 |
| 91 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79881669 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79820806 |
| 93 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.79788986 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79637265 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78737995 |
| 96 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78448002 |
| 97 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78318429 |
| 98 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.77810283 |
| 99 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.76242495 |
| 100 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74536294 |
| 101 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72678655 |
| 102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.72575130 |
| 103 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68964258 |
| 104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68338040 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67260874 |
| 106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66813627 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.65439915 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65259748 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64469498 |
| 110 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62314454 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.61210849 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60773595 |
| 113 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.59127459 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58594490 |
| 115 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57789848 |
| 116 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56271438 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.55960664 |
| 118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.55231220 |
| 119 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.53968918 |
| 120 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.51789697 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51756743 |
| 122 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.50280564 |
| 123 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50248730 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48470102 |
| 125 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.47167105 |
| 126 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46935339 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46873134 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46261120 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45782716 |
| 130 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45596658 |
| 131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.45384950 |
| 132 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45065207 |
| 133 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.44408314 |
| 134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44268672 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43388435 |
| 136 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42955840 |
| 137 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.42451229 |
| 138 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.41339214 |
| 139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41045346 |
| 140 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39806889 |
| 141 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.39453774 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.38744505 |
| 143 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38590699 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.38405137 |
| 145 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.38388387 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.38243546 |
| 147 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.38186821 |
| 148 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.38063128 |
| 149 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.38063128 |
| 150 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.37585439 |
| 151 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.36802834 |
| 152 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.36525774 |
| 153 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36257782 |
| 154 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35878165 |
| 155 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35111101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.59016995 |
| 2 | MP0005360_urolithiasis | 7.12483234 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.94075995 |
| 4 | MP0005365_abnormal_bile_salt | 5.82259142 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.86672616 |
| 6 | MP0004272_abnormal_basement_membrane | 4.07384950 |
| 7 | MP0003950_abnormal_plasma_membrane | 3.97839888 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.83633568 |
| 9 | MP0003252_abnormal_bile_duct | 3.65427027 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.65148772 |
| 11 | MP0009840_abnormal_foam_cell | 3.10275831 |
| 12 | MP0001958_emphysema | 3.07363445 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.81916959 |
| 14 | MP0005332_abnormal_amino_acid | 2.78444236 |
| 15 | MP0003195_calcinosis | 2.60100034 |
| 16 | MP0005083_abnormal_biliary_tract | 2.58222394 |
| 17 | MP0006054_spinal_hemorrhage | 2.43069779 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.30435681 |
| 19 | MP0005670_abnormal_white_adipose | 2.26335367 |
| 20 | MP0005257_abnormal_intraocular_pressure | 2.25024865 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.19466616 |
| 22 | MP0000609_abnormal_liver_physiology | 2.15348362 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.14096304 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.00791990 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.96314023 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.84035647 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.82064201 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.80409071 |
| 29 | MP0002108_abnormal_muscle_morphology | 1.79934237 |
| 30 | MP0005623_abnormal_meninges_morphology | 1.75170531 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.72739794 |
| 32 | MP0003868_abnormal_feces_composition | 1.70689735 |
| 33 | MP0001764_abnormal_homeostasis | 1.69937813 |
| 34 | MP0000751_myopathy | 1.67231149 |
| 35 | MP0001879_abnormal_lymphatic_vessel | 1.66830775 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.64680289 |
| 37 | MP0005508_abnormal_skeleton_morphology | 1.58532410 |
| 38 | MP0003091_abnormal_cell_migration | 1.58454422 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.57475060 |
| 40 | MP0003186_abnormal_redox_activity | 1.56013057 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55617878 |
| 42 | MP0000749_muscle_degeneration | 1.45457471 |
| 43 | MP0003011_delayed_dark_adaptation | 1.40310991 |
| 44 | MP0009697_abnormal_copulation | 1.34560785 |
| 45 | MP0004130_abnormal_muscle_cell | 1.31857505 |
| 46 | MP0000003_abnormal_adipose_tissue | 1.31018653 |
| 47 | MP0004233_abnormal_muscle_weight | 1.28067174 |
| 48 | MP0010386_abnormal_urinary_bladder | 1.25241147 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.24959117 |
| 50 | MP0005451_abnormal_body_composition | 1.24687695 |
| 51 | MP0010030_abnormal_orbit_morphology | 1.23157298 |
| 52 | MP0005666_abnormal_adipose_tissue | 1.21778022 |
| 53 | MP0000598_abnormal_liver_morphology | 1.17775598 |
| 54 | MP0002896_abnormal_bone_mineralization | 1.17018109 |
| 55 | MP0002876_abnormal_thyroid_physiology | 1.14751446 |
| 56 | MP0000750_abnormal_muscle_regeneration | 1.14234629 |
| 57 | MP0002971_abnormal_brown_adipose | 1.13309856 |
| 58 | MP0009250_abnormal_appendicular_skeleto | 1.11576429 |
| 59 | MP0009764_decreased_sensitivity_to | 1.11032933 |
| 60 | MP0002933_joint_inflammation | 1.08657534 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.07777288 |
| 62 | MP0009763_increased_sensitivity_to | 1.07648418 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.06725595 |
| 64 | MP0000733_abnormal_muscle_development | 1.06524969 |
| 65 | MP0000604_amyloidosis | 1.03949921 |
| 66 | MP0005647_abnormal_sex_gland | 1.03551627 |
| 67 | MP0002254_reproductive_system_inflammat | 1.01342953 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.00567435 |
| 69 | MP0002282_abnormal_trachea_morphology | 1.00502736 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 0.98642543 |
| 71 | MP0005275_abnormal_skin_tensile | 0.97619748 |
| 72 | MP0005334_abnormal_fat_pad | 0.97156697 |
| 73 | MP0001299_abnormal_eye_distance/ | 0.96844335 |
| 74 | MP0001661_extended_life_span | 0.93355796 |
| 75 | MP0005165_increased_susceptibility_to | 0.92637496 |
| 76 | MP0005390_skeleton_phenotype | 0.92574012 |
| 77 | MP0003941_abnormal_skin_development | 0.91804580 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 0.91786122 |
| 79 | MP0000343_altered_response_to | 0.90627869 |
| 80 | MP0000762_abnormal_tongue_morphology | 0.86805846 |
| 81 | MP0008469_abnormal_protein_level | 0.86767836 |
| 82 | MP0001915_intracranial_hemorrhage | 0.84553231 |
| 83 | MP0009642_abnormal_blood_homeostasis | 0.84299598 |
| 84 | MP0004858_abnormal_nervous_system | 0.84180167 |
| 85 | MP0005535_abnormal_body_temperature | 0.83983029 |
| 86 | MP0003690_abnormal_glial_cell | 0.83613919 |
| 87 | MP0002078_abnormal_glucose_homeostasis | 0.83260933 |
| 88 | MP0005376_homeostasis/metabolism_phenot | 0.83102622 |
| 89 | MP0000747_muscle_weakness | 0.82418404 |
| 90 | MP0000163_abnormal_cartilage_morphology | 0.81338758 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.80810057 |
| 92 | MP0003828_pulmonary_edema | 0.79608145 |
| 93 | MP0002128_abnormal_blood_circulation | 0.79495753 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.78351387 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.77952176 |
| 96 | MP0002269_muscular_atrophy | 0.76917194 |
| 97 | MP0003724_increased_susceptibility_to | 0.76164957 |
| 98 | MP0009115_abnormal_fat_cell | 0.75234731 |
| 99 | MP0009765_abnormal_xenobiotic_induced | 0.75086509 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.74934924 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.72148160 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.71367303 |
| 103 | MP0004084_abnormal_cardiac_muscle | 0.70260061 |
| 104 | MP0005408_hypopigmentation | 0.69965921 |
| 105 | MP0003385_abnormal_body_wall | 0.68195860 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.68073303 |
| 107 | MP0002060_abnormal_skin_morphology | 0.67876780 |
| 108 | MP0001756_abnormal_urination | 0.67625345 |
| 109 | MP0004087_abnormal_muscle_fiber | 0.67264653 |
| 110 | MP0005448_abnormal_energy_balance | 0.67043531 |
| 111 | MP0005220_abnormal_exocrine_pancreas | 0.65022114 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.64968397 |
| 113 | MP0005197_abnormal_uvea_morphology | 0.64695137 |
| 114 | MP0003448_altered_tumor_morphology | 0.64160014 |
| 115 | MP0005193_abnormal_anterior_eye | 0.64052755 |
| 116 | MP0005266_abnormal_metabolism | 0.63146080 |
| 117 | MP0001614_abnormal_blood_vessel | 0.61807681 |
| 118 | MP0002970_abnormal_white_adipose | 0.61386682 |
| 119 | MP0000467_abnormal_esophagus_morphology | 0.61314720 |
| 120 | MP0005330_cardiomyopathy | 0.60264307 |
| 121 | MP0002115_abnormal_skeleton_extremities | 0.58939611 |
| 122 | MP0002113_abnormal_skeleton_development | 0.58826283 |
| 123 | MP0009053_abnormal_anal_canal | 0.58763827 |
| 124 | MP0000538_abnormal_urinary_bladder | 0.57918283 |
| 125 | MP0002932_abnormal_joint_morphology | 0.57460289 |
| 126 | MP0001175_abnormal_lung_morphology | 0.57129419 |
| 127 | MP0005388_respiratory_system_phenotype | 0.56891604 |
| 128 | MP0002133_abnormal_respiratory_system | 0.56891604 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.56865914 |
| 130 | MP0000534_abnormal_ureter_morphology | 0.56697600 |
| 131 | MP0005369_muscle_phenotype | 0.55319941 |
| 132 | MP0001243_abnormal_dermal_layer | 0.53910208 |
| 133 | MP0000639_abnormal_adrenal_gland | 0.53493579 |
| 134 | MP0005395_other_phenotype | 0.52935888 |
| 135 | MP0005164_abnormal_response_to | 0.52486575 |
| 136 | MP0002168_other_aberrant_phenotype | 0.52230371 |
| 137 | MP0003329_amyloid_beta_deposits | 0.52011948 |
| 138 | MP0005023_abnormal_wound_healing | 0.48888175 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.47999371 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.47606014 |
| 141 | MP0003436_decreased_susceptibility_to | 0.47176763 |
| 142 | MP0003959_abnormal_lean_body | 0.47073237 |
| 143 | MP0001881_abnormal_mammary_gland | 0.46414080 |
| 144 | MP0000249_abnormal_blood_vessel | 0.45156843 |
| 145 | MP0003075_altered_response_to | 0.45040244 |
| 146 | MP0008874_decreased_physiological_sensi | 0.45014266 |
| 147 | MP0004883_abnormal_blood_vessel | 0.44979666 |
| 148 | MP0005464_abnormal_platelet_physiology | 0.44636153 |
| 149 | MP0008873_increased_physiological_sensi | 0.44154633 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.42339335 |
| 151 | MP0005595_abnormal_vascular_smooth | 0.42005975 |
| 152 | MP0003953_abnormal_hormone_level | 0.41204964 |
| 153 | MP0003638_abnormal_response/metabolism_ | 0.40929771 |
| 154 | MP0002796_impaired_skin_barrier | 0.40724504 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.37156432 |
| 156 | MP0006035_abnormal_mitochondrial_morpho | 0.37144459 |
| 157 | MP0003279_aneurysm | 0.36778296 |
| 158 | MP0005248_abnormal_Harderian_gland | 0.36655018 |
| 159 | MP0009672_abnormal_birth_weight | 0.35995574 |
| 160 | MP0005503_abnormal_tendon_morphology | 0.35189044 |
| 161 | MP0001542_abnormal_bone_strength | 0.34861544 |
| 162 | MP0005166_decreased_susceptibility_to | 0.34790637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.28117448 |
| 2 | Premature rupture of membranes (HP:0001788) | 7.10255972 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.97908977 |
| 4 | Protrusio acetabuli (HP:0003179) | 6.73717883 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64503799 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 6.53732539 |
| 7 | Xanthomatosis (HP:0000991) | 6.23953336 |
| 8 | Prolonged partial thromboplastin time (HP:0003645) | 6.00965987 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 5.84103785 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.83593470 |
| 11 | Complement deficiency (HP:0004431) | 5.78566004 |
| 12 | Aortic dissection (HP:0002647) | 5.31982308 |
| 13 | Aortic aneurysm (HP:0004942) | 4.81706053 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.71834756 |
| 15 | Hyperammonemia (HP:0001987) | 4.68500607 |
| 16 | Epidermoid cyst (HP:0200040) | 4.64461880 |
| 17 | Vascular tortuosity (HP:0004948) | 4.61650433 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 4.49229266 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.48358889 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.44164726 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.43779044 |
| 22 | Joint hemorrhage (HP:0005261) | 4.41837697 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 4.37866633 |
| 24 | Abnormality of complement system (HP:0005339) | 4.28891883 |
| 25 | Ketosis (HP:0001946) | 4.24163309 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23987787 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23939698 |
| 28 | Soft skin (HP:0000977) | 4.19367008 |
| 29 | Hyperglycinemia (HP:0002154) | 4.14936127 |
| 30 | Arterial tortuosity (HP:0005116) | 4.09017400 |
| 31 | Hyperglycinuria (HP:0003108) | 4.07714157 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 3.95861889 |
| 33 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.95861889 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.79742675 |
| 35 | Atrophic scars (HP:0001075) | 3.69350280 |
| 36 | Hypoglycemic coma (HP:0001325) | 3.67672658 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.65343236 |
| 38 | Fat malabsorption (HP:0002630) | 3.59725792 |
| 39 | Follicular hyperkeratosis (HP:0007502) | 3.53511744 |
| 40 | Popliteal pterygium (HP:0009756) | 3.52604368 |
| 41 | Hypercholesterolemia (HP:0003124) | 3.52078332 |
| 42 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51277475 |
| 43 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46236484 |
| 44 | Vertebral compression fractures (HP:0002953) | 3.36645719 |
| 45 | Spondylolisthesis (HP:0003302) | 3.36551444 |
| 46 | Bladder diverticulum (HP:0000015) | 3.34417969 |
| 47 | Wormian bones (HP:0002645) | 3.31975854 |
| 48 | Spontaneous abortion (HP:0005268) | 3.31279564 |
| 49 | Cervical subluxation (HP:0003308) | 3.30585929 |
| 50 | Fragile skin (HP:0001030) | 3.26841044 |
| 51 | Myocardial infarction (HP:0001658) | 3.22796222 |
| 52 | Blue sclerae (HP:0000592) | 3.21835559 |
| 53 | Abnormality of dentin (HP:0010299) | 3.18450437 |
| 54 | Type 1 muscle fiber predominance (HP:0003803) | 3.14247089 |
| 55 | Abnormality of serum amino acid levels (HP:0003112) | 3.12073651 |
| 56 | Cerebral aneurysm (HP:0004944) | 3.11075806 |
| 57 | Ankle contracture (HP:0006466) | 3.10539947 |
| 58 | Skin nodule (HP:0200036) | 3.07999837 |
| 59 | Wrist flexion contracture (HP:0001239) | 3.04745883 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 3.01967786 |
| 61 | Dilatation of the ascending aorta (HP:0005111) | 3.01578571 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.96851778 |
| 63 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95699761 |
| 64 | Ketoacidosis (HP:0001993) | 2.95021355 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.92129384 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.88953314 |
| 67 | Abnormal delivery (HP:0001787) | 2.86393897 |
| 68 | Steatorrhea (HP:0002570) | 2.77289065 |
| 69 | Delayed CNS myelination (HP:0002188) | 2.72265592 |
| 70 | Genu recurvatum (HP:0002816) | 2.69442294 |
| 71 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.65004759 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.65004759 |
| 73 | Amyloidosis (HP:0011034) | 2.63878121 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.63080341 |
| 75 | Metabolic acidosis (HP:0001942) | 2.62729894 |
| 76 | Lethargy (HP:0001254) | 2.62639105 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.57327225 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57327225 |
| 79 | Mitral stenosis (HP:0001718) | 2.56928892 |
| 80 | Mitral valve prolapse (HP:0001634) | 2.56339328 |
| 81 | Spinal rigidity (HP:0003306) | 2.55175032 |
| 82 | Broad metatarsal (HP:0001783) | 2.54919353 |
| 83 | Shallow orbits (HP:0000586) | 2.54113554 |
| 84 | Spastic diplegia (HP:0001264) | 2.53377684 |
| 85 | Cerebral edema (HP:0002181) | 2.52059987 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 2.50334927 |
| 87 | Aortic regurgitation (HP:0001659) | 2.48202246 |
| 88 | Biconcave vertebral bodies (HP:0004586) | 2.48077014 |
| 89 | Hyperextensible skin (HP:0000974) | 2.43727019 |
| 90 | Glomerulonephritis (HP:0000099) | 2.40109123 |
| 91 | Neonatal onset (HP:0003623) | 2.38628115 |
| 92 | Round ear (HP:0100830) | 2.36645173 |
| 93 | Joint stiffness (HP:0001387) | 2.36485113 |
| 94 | Pterygium (HP:0001059) | 2.34481600 |
| 95 | Abnormality of placental membranes (HP:0011409) | 2.33893703 |
| 96 | Amniotic constriction ring (HP:0009775) | 2.33893703 |
| 97 | Hydroxyprolinuria (HP:0003080) | 2.32793471 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 2.32793471 |
| 99 | Vascular calcification (HP:0004934) | 2.32303566 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.31565734 |
| 101 | Irritability (HP:0000737) | 2.29517568 |
| 102 | Aneurysm (HP:0002617) | 2.28870690 |
| 103 | Hypertriglyceridemia (HP:0002155) | 2.28860887 |
| 104 | Aortic valve stenosis (HP:0001650) | 2.27872789 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.26357674 |
| 106 | Cardiovascular calcification (HP:0011915) | 2.26147528 |
| 107 | Abnormal gallbladder morphology (HP:0012437) | 2.25899264 |
| 108 | Pancreatitis (HP:0001733) | 2.24896611 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 2.24752914 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 2.23594239 |
| 111 | Gout (HP:0001997) | 2.23227294 |
| 112 | Fatigable weakness (HP:0003473) | 2.23061343 |
| 113 | Abnormality of the neuromuscular junction (HP:0003398) | 2.23061343 |
| 114 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22354757 |
| 115 | Gingival bleeding (HP:0000225) | 2.21582720 |
| 116 | Cholelithiasis (HP:0001081) | 2.20772745 |
| 117 | Abnormality of the acetabulum (HP:0003170) | 2.19533296 |
| 118 | Brushfield spots (HP:0001088) | 2.19331795 |
| 119 | Joint laxity (HP:0001388) | 2.19286209 |
| 120 | Striae distensae (HP:0001065) | 2.17861393 |
| 121 | Aplasia of the musculature (HP:0100854) | 2.16308477 |
| 122 | Elbow flexion contracture (HP:0002987) | 2.16061298 |
| 123 | Mesomelia (HP:0003027) | 2.13789850 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 2.13616421 |
| 125 | Ectopia lentis (HP:0001083) | 2.12193868 |
| 126 | Overgrowth (HP:0001548) | 2.11348839 |
| 127 | Slender build (HP:0001533) | 2.10208904 |
| 128 | Hypoglycemic seizures (HP:0002173) | 2.10147714 |
| 129 | Vomiting (HP:0002013) | 2.10027611 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 2.09858301 |
| 131 | Cholecystitis (HP:0001082) | 2.09858301 |
| 132 | Hemorrhage of the eye (HP:0011885) | 2.06812551 |
| 133 | Enlarged kidneys (HP:0000105) | 2.05071010 |
| 134 | Thrombophlebitis (HP:0004418) | 2.04765247 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 2.04149171 |
| 136 | Ulnar bowing (HP:0003031) | 2.04027293 |
| 137 | Generalized amyotrophy (HP:0003700) | 2.03710161 |
| 138 | Sensorimotor neuropathy (HP:0007141) | 2.03201127 |
| 139 | Mitral regurgitation (HP:0001653) | 2.02134248 |
| 140 | Esophageal varix (HP:0002040) | 2.02079267 |
| 141 | Acanthocytosis (HP:0001927) | 1.99676901 |
| 142 | Ulnar deviation of the wrist (HP:0003049) | 1.99509535 |
| 143 | Muscle fiber atrophy (HP:0100295) | 1.98497622 |
| 144 | Opisthotonus (HP:0002179) | 1.97990657 |
| 145 | Nonimmune hydrops fetalis (HP:0001790) | 1.97532124 |
| 146 | Menorrhagia (HP:0000132) | 1.93805799 |
| 147 | Bowel diverticulosis (HP:0005222) | 1.93686907 |
| 148 | Generalized aminoaciduria (HP:0002909) | 1.93547066 |
| 149 | Delayed gross motor development (HP:0002194) | 1.91810086 |
| 150 | Wide anterior fontanel (HP:0000260) | 1.90213741 |
| 151 | Thin ribs (HP:0000883) | 1.87777658 |
| 152 | Late onset (HP:0003584) | 1.87055600 |
| 153 | Glucose intolerance (HP:0000833) | 1.86080521 |
| 154 | Weak cry (HP:0001612) | 1.85919403 |
| 155 | Hyperglycemia (HP:0003074) | 1.85908618 |
| 156 | Nephritis (HP:0000123) | 1.85833153 |
| 157 | Abnormality of iron homeostasis (HP:0011031) | 1.85323654 |
| 158 | Malnutrition (HP:0004395) | 1.84612208 |
| 159 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.84395914 |
| 160 | Gowers sign (HP:0003391) | 1.84147004 |
| 161 | Abnormality of the gallbladder (HP:0005264) | 1.82803305 |
| 162 | Absent frontal sinuses (HP:0002688) | 1.82388738 |
| 163 | Coronal craniosynostosis (HP:0004440) | 1.82184485 |
| 164 | Pulmonary artery stenosis (HP:0004415) | 1.79923483 |
| 165 | Coxa vara (HP:0002812) | 1.78971853 |
| 166 | Delayed cranial suture closure (HP:0000270) | 1.78765054 |
| 167 | Elevated hepatic transaminases (HP:0002910) | 1.78712683 |
| 168 | Spinal cord compression (HP:0002176) | 1.78294795 |
| 169 | Venous insufficiency (HP:0005293) | 1.77985776 |
| 170 | Venous abnormality (HP:0002624) | 1.77891558 |
| 171 | Short nail (HP:0001799) | 1.77356753 |
| 172 | Alkalosis (HP:0001948) | 1.77006622 |
| 173 | Osteoarthritis (HP:0002758) | 1.76986529 |
| 174 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76574092 |
| 175 | Metaphyseal dysplasia (HP:0100255) | 1.76384057 |
| 176 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.75587508 |
| 177 | Peritonitis (HP:0002586) | 1.73590916 |
| 178 | Back pain (HP:0003418) | 1.72694262 |
| 179 | Renal cortical cysts (HP:0000803) | 1.71575288 |
| 180 | Increased purine levels (HP:0004368) | 1.67945280 |
| 181 | Hyperuricemia (HP:0002149) | 1.67945280 |
| 182 | Nausea (HP:0002018) | 1.67059854 |
| 183 | Abnormality of the Achilles tendon (HP:0005109) | 1.66014434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.86049373 |
| 2 | MUSK | 5.71336974 |
| 3 | ERN1 | 5.09647501 |
| 4 | SIK1 | 4.34820272 |
| 5 | FGFR4 | 4.03526044 |
| 6 | TRIB3 | 3.16571683 |
| 7 | ERBB4 | 2.83175190 |
| 8 | MAP3K12 | 2.63353716 |
| 9 | LIMK1 | 2.56679628 |
| 10 | INSRR | 2.48083296 |
| 11 | MST1R | 2.24560620 |
| 12 | TESK1 | 2.23273999 |
| 13 | PAK4 | 2.05505106 |
| 14 | PKN2 | 1.91809062 |
| 15 | MAP2K4 | 1.85528188 |
| 16 | TTN | 1.84271981 |
| 17 | CAMK1D | 1.78595064 |
| 18 | LATS1 | 1.73480122 |
| 19 | TAOK3 | 1.71880067 |
| 20 | MAPK11 | 1.71322572 |
| 21 | MOS | 1.62672361 |
| 22 | NEK9 | 1.60856930 |
| 23 | FRK | 1.57645141 |
| 24 | FLT3 | 1.54092792 |
| 25 | ABL2 | 1.53645041 |
| 26 | PIK3CG | 1.51829708 |
| 27 | ILK | 1.48912664 |
| 28 | NTRK1 | 1.46917019 |
| 29 | TRPM7 | 1.44367951 |
| 30 | TYK2 | 1.31716878 |
| 31 | EPHA3 | 1.31213305 |
| 32 | FGFR2 | 1.31071805 |
| 33 | PTK6 | 1.26975536 |
| 34 | PRKAA2 | 1.25042355 |
| 35 | PDGFRB | 1.22949509 |
| 36 | PRKD2 | 1.19974464 |
| 37 | RIPK1 | 1.14695541 |
| 38 | CDC42BPA | 1.13859218 |
| 39 | EPHA2 | 1.13524956 |
| 40 | KDR | 1.13478063 |
| 41 | MAPKAPK3 | 1.10986066 |
| 42 | JAK2 | 1.10549432 |
| 43 | LATS2 | 1.09821262 |
| 44 | MET | 1.09411246 |
| 45 | TBK1 | 1.08063159 |
| 46 | JAK1 | 1.07805866 |
| 47 | DAPK3 | 1.05307010 |
| 48 | PIM2 | 1.03431382 |
| 49 | ARAF | 1.03073547 |
| 50 | MAP2K3 | 0.99075027 |
| 51 | ROCK1 | 0.98510751 |
| 52 | STK38 | 0.97251647 |
| 53 | DAPK2 | 0.96345708 |
| 54 | MAP3K3 | 0.95847614 |
| 55 | CDK6 | 0.94555187 |
| 56 | PDK4 | 0.92848920 |
| 57 | PDK3 | 0.92848920 |
| 58 | CAMK1G | 0.91582523 |
| 59 | ERBB2 | 0.91416579 |
| 60 | TGFBR2 | 0.90524287 |
| 61 | EPHB1 | 0.90291094 |
| 62 | CDK8 | 0.90227628 |
| 63 | STK38L | 0.90209577 |
| 64 | LMTK2 | 0.90111995 |
| 65 | FGFR3 | 0.89200875 |
| 66 | PINK1 | 0.89118241 |
| 67 | ADRBK1 | 0.89064660 |
| 68 | MAP2K1 | 0.87577254 |
| 69 | PDGFRA | 0.86383200 |
| 70 | MAPK4 | 0.82573295 |
| 71 | MAP3K7 | 0.80509234 |
| 72 | TIE1 | 0.77046912 |
| 73 | MAPK12 | 0.76851041 |
| 74 | EPHB2 | 0.76272146 |
| 75 | PRKACG | 0.75769735 |
| 76 | PRKCZ | 0.75266636 |
| 77 | ROCK2 | 0.74574547 |
| 78 | PIK3CA | 0.74124895 |
| 79 | GSK3A | 0.68287305 |
| 80 | CAMK2G | 0.67126324 |
| 81 | GRK6 | 0.66132360 |
| 82 | MAP3K11 | 0.65901959 |
| 83 | NEK1 | 0.63950775 |
| 84 | MYLK | 0.63813177 |
| 85 | GRK1 | 0.62774256 |
| 86 | PTK2 | 0.62555789 |
| 87 | MAP3K14 | 0.62051188 |
| 88 | PRKAA1 | 0.61656559 |
| 89 | CLK1 | 0.61525359 |
| 90 | IRAK3 | 0.58977294 |
| 91 | PDPK1 | 0.58012408 |
| 92 | IGF1R | 0.57898633 |
| 93 | EIF2AK3 | 0.57196179 |
| 94 | PRKG2 | 0.57153946 |
| 95 | NME2 | 0.56264047 |
| 96 | CSK | 0.56234127 |
| 97 | STK24 | 0.56211469 |
| 98 | MELK | 0.55682726 |
| 99 | PDK2 | 0.53006602 |
| 100 | FER | 0.52604500 |
| 101 | MAP3K6 | 0.51780803 |
| 102 | DMPK | 0.51581570 |
| 103 | EIF2AK1 | 0.51170087 |
| 104 | DDR2 | 0.49722329 |
| 105 | DYRK1B | 0.48884188 |
| 106 | TAOK2 | 0.48716115 |
| 107 | MAP3K10 | 0.48624449 |
| 108 | RET | 0.48423279 |
| 109 | PRKCE | 0.47515777 |
| 110 | MTOR | 0.47405399 |
| 111 | BMX | 0.47360957 |
| 112 | NLK | 0.45486640 |
| 113 | ZAP70 | 0.45024945 |
| 114 | CSF1R | 0.44249308 |
| 115 | PAK6 | 0.43288126 |
| 116 | MAP3K5 | 0.43020336 |
| 117 | MAPK7 | 0.42104982 |
| 118 | MAP2K6 | 0.41601117 |
| 119 | IKBKE | 0.40440811 |
| 120 | PAK3 | 0.40243913 |
| 121 | IRAK1 | 0.40048941 |
| 122 | AKT3 | 0.37162156 |
| 123 | PTK2B | 0.36656138 |
| 124 | SGK3 | 0.36344317 |
| 125 | PRKD3 | 0.36204898 |
| 126 | STK3 | 0.35318685 |
| 127 | CAMK2D | 0.35258249 |
| 128 | PLK2 | 0.34764218 |
| 129 | PRKCH | 0.33929825 |
| 130 | JAK3 | 0.33760282 |
| 131 | MAP3K2 | 0.33593725 |
| 132 | MAPK15 | 0.32787022 |
| 133 | PAK1 | 0.32207059 |
| 134 | PKN1 | 0.31930343 |
| 135 | RPS6KA2 | 0.31909658 |
| 136 | MAPKAPK2 | 0.31802592 |
| 137 | PAK2 | 0.31521761 |
| 138 | FGFR1 | 0.31496330 |
| 139 | EGFR | 0.30470735 |
| 140 | CSNK1G1 | 0.30383866 |
| 141 | STK16 | 0.28972542 |
| 142 | PDK1 | 0.28496472 |
| 143 | CDK4 | 0.27719805 |
| 144 | GRK5 | 0.27711826 |
| 145 | KIT | 0.27706731 |
| 146 | ABL1 | 0.27110733 |
| 147 | PRKCQ | 0.25353440 |
| 148 | PRKD1 | 0.24624819 |
| 149 | PRKCG | 0.22764802 |
| 150 | INSR | 0.22488286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.42778918 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.59428560 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53749309 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.27738823 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.26971600 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10429603 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80370014 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62754841 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54774440 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53501535 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49243259 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47066445 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.40935742 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16892687 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.12490940 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.11094543 |
| 17 | Focal adhesion_Homo sapiens_hsa04510 | 2.11085566 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.10663287 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.10408924 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.09972926 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04470363 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95865275 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89321260 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86069867 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85663763 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82297610 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80518897 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79539389 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78219162 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.76085931 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73148776 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70330777 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.67112222 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63472291 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63419738 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60936443 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54694884 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.50669438 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49784592 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43683240 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42335691 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34854342 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32994147 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.32308736 |
| 45 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32303407 |
| 46 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30319604 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29996451 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24952846 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.22096893 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.21879954 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.21605617 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19504873 |
| 53 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18587081 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17285317 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 1.15778142 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12291002 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02471343 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02249025 |
| 59 | ABC transporters_Homo sapiens_hsa02010 | 1.01909192 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97345754 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93427944 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92735191 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89353316 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89118453 |
| 65 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.88130083 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86514548 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83792785 |
| 68 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80563520 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80430269 |
| 70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80334903 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80323521 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79590007 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.77829099 |
| 74 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76671100 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.74958646 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.72620975 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72146018 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.72078019 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.71048858 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70023922 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69162843 |
| 82 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68128024 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66366055 |
| 84 | * Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.64277258 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64086947 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60658482 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57905917 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49159560 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.45617178 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.44870470 |
| 91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44639461 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44526081 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42756800 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.41883811 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40963148 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39007939 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.34835475 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33394376 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.32970319 |
| 100 | Bladder cancer_Homo sapiens_hsa05219 | 0.32075788 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.32056583 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29619961 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29377101 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.24760323 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23600805 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22492474 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22361494 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20684144 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19589766 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16882195 |
| 111 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.08715366 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03160734 |
| 113 | Pertussis_Homo sapiens_hsa05133 | -0.2033997 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1976116 |
| 115 | Malaria_Homo sapiens_hsa05144 | -0.1934428 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | -0.1721582 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1688507 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1688033 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1625451 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1578502 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1513696 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1468512 |
| 123 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1422050 |
| 124 | Amoebiasis_Homo sapiens_hsa05146 | -0.1087436 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1057278 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0924989 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0847811 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0764186 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0543907 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0274129 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0106790 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0094464 |

